BioWaveGO BWG-S
BioWaveGO BWG-S is a medical device (FDA Class II; FDA product code GZJ, Stimulator, Nerve, Transcutaneous, For Pain Relief) made by BioWave Corporation, cleared under FDA 510(k) K180943 on 17 Aug 2018 and listed in FDA GUDID since 26 Jul 2021 (UDI-DI 00859911006010), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00859911006010 | Date26 Jul 2021 | StatusListed |
| United States | FDA 510(k)SESE | NumberK180943 | Date17 Aug 2018 | StatusActive |
Official records
- AccessGUDID record 00859911006010
- FDA 510(k) database K180943
From the FDA record
- Device description
- BioWaveGO Neurostimulator
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K180943 decided 17 Aug 2018 Active
- FDA GUDID UDI-DI 00859911006010 listed 26 Jul 2021 Listed
Timeline
- Cleared FDA 510(k) K180943
- Listed FDA GUDID 00859911006010
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- BioWaveGO
- Generic name
- Physical therapy transcutaneous neuromuscular electrical stimulation system
- Model / reference
- BWG-S
- Primary DI / UDI-DI
- 00859911006010
- 510(k) Number
- FDA product code
- GZJ
- GMDN term
- Physical therapy transcutaneous neuromuscular electrical stimulation system
- Device class
- Class II
- Regulation number
- 882.5890
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Analgesic transcutaneous electrical nerve stimulation system.